Home » Topics » Regulatory » Patents

Patents
RSS

Novel annelated pyridazines claimed by Amgen for cancer treatment

April 17, 2009

Takeda claims novel tyrosine kinase inhibitors

April 17, 2009

Arete Therapeutics presents epoxide hydrolase inhibitors for the treatment of hypertension

April 16, 2009

Boehringer Ingelheim claims novel calcitonin gene-related peptide antagonists

April 16, 2009

Abbott describes novel prodrugs of a histamine H3 receptor ligand

April 16, 2009

T-type calcium channel inhibitors claimed by Ewha Womans University as analgesics

April 16, 2009

Novel MEK inhibitors identified by Curis

April 16, 2009

Novel compounds for the treatment of diabetes discovered by Kyorin and ActivX

April 15, 2009

Sanofi-aventis and Mitsubishi Tanabe Pharma claim novel tau protein kinase inhibitors

April 15, 2009

Roche claims novel NK3 receptor antagonists

April 15, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...